Ameriprise’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Buy
36,521
+371
+1% +$2.5K ﹤0.01% 3919
2026
Q1
$236K Sell
36,150
-442
-1% -$2.75K ﹤0.01% 3829
2025
Q4
$209K Hold
36,592
﹤0.01% 3910
2025
Q3
$250K Sell
36,592
-258
-0.7% -$1.95K ﹤0.01% 3848
2025
Q2
$331K Buy
+36,850
New +$218K ﹤0.01% 3665

Other funds holding ULBI

Ameriprise's ULBI Position: Q2 2026 in Review

Ameriprise increased its Ultralife (ULBI) stake by 1% in Q2 2026, buying an estimated $2.5K and bringing the position to 36,521 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #3919.

Ameriprise first reported a position in ULBI in Q2 2025 and has held it in 5 quarters since. The position peaked at $331K in Q2 2025. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • Ameriprise held 36,521 shares of Ultralife worth $231K as of Q2 2026.
  • Ameriprise bought 371 Ultralife shares in Q2 2026, an estimated $2.5K.
  • Ultralife made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3919 holding.
  • Ameriprise first reported a position in Ultralife in Q2 2025 and has held it in 5 quarters since.
  • Ameriprise's Ultralife position peaked at $331K in Q2 2025.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.